% Expired Patents = 33.3

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 5

Loading Chart...

4 inventors (with patents filed for the assignee):

Jianhui Guo (2 out of 12 patents)

Dong An (2 out of 4 patents)

Yaoru Lu (1 out of 1 patent)

4. Jianghui Guo (1 out of 1 patent)

5. Yong Jiang (65 patents)

6. Meng Wang (15 patents)

7. Xiaofang Zhang (2 patents)

8. Jian-Hui Guo (0 patent)

3 patents: Sort by Forward Citations

1. 8138214 - Pharmaceutical composition (2012-03-20),

2. 7943648 - Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same (2011-05-17),

3. 7858651 - Imidazole-5-carboxylic acid derivatives, the preparation method therefor and the uses thereof (2010-12-28),

Company Overview

Shanghai Allist Pharmaceutical, Inc. is a leading biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative therapeutics. With a strong focus on oncology and metabolic diseases, Allist leverages advanced technologies and scientific expertise to deliver high-quality healthcare solutions. The company aims to enhance patient outcomes by providing effective, safe, and accessible medications on a global scale. Through strategic partnerships and a commitment to excellence, Shanghai Allist continues to expand its pipeline and reach within the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#657 in Shanghai

#8,360 in China

Shanghai, China

Shanghai Allist Pharmaceutical, Inc.

Forward Citations = 5

4 inventors:

Jianhui Guo (2 out of 12 patents)

Dong An (2 out of 4 patents)

Yaoru Lu (1 out of 1 patent)

4. Jianghui Guo (1 out of 1 patent)

5. Yong Jiang (65 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shanghai Allist Pharmaceutical, Inc.. Retrieved from https://idiyas.com/company/shanghai-allist-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]